Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kadere Konte"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/443d415ed8d34f8fb170c8c4e3b31fd0
Autor:
Kadère Konté, Liza Afzali-Hashemi, Koen Baas, Anouk Schrantee, Erfan Nur, Aart Nederveen, Bart Biemond
Publikováno v:
HemaSphere, Vol 7, p e53603b7 (2023)
Externí odkaz:
https://doaj.org/article/804939aaa9e24632bc9cc2b1192899cb
Publikováno v:
HemaSphere, Vol 7, p e4935435 (2023)
Externí odkaz:
https://doaj.org/article/1cabc175502549e4a238d163a841e535
Autor:
Kadère Konté, Aafke Gaartman, Rob van Zwieten, Martijn Veldthuis, Robin van Bruggen, Bart Biemond, Erfan Nur
Publikováno v:
HemaSphere, Vol 7, p e0036284 (2023)
Externí odkaz:
https://doaj.org/article/df87c2d4fe4b438a95a6474ecf669747
Autor:
Erfan Nur, Man Wai Tang, Charlotte F.J. van Tuijn, Jarom Heijmans, Kadere Konte, Bart J. Biemond
Publikováno v:
International Journal of Laboratory Hematology
International journal of laboratory hematology, 44(2), e87-e90. Wiley-Blackwell
International journal of laboratory hematology, 44(2), e87-e90. Wiley-Blackwell
Autor:
Berrie Meijer, Mark Löwenberg, Nanne K. H. de Boer, Kadere Konte, Geert R. D'Haens, Sara van Gennep, Martijn W. Heymans
Publikováno v:
van Gennep, S, Konté, K, Meijer, B, Heymans, M W, D’Haens, G R, Löwenberg, M & de Boer, N K H 2019, ' Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 5, pp. 484-506 . https://doi.org/10.1111/apt.15403
Background: Thiopurine-induced leukopenia, a frequently observed and potentially life-threatening adverse event, complicates the clinical management of IBD patients. Aim: To assess risk factors for thiopurine-induced leukopenia in IBD. Methods: MEDLI
Autor:
Sybren L. Meijer, Yi Zhang, Nicola F Frei, Fiebo J.W. ten Kate, Jacques J. Bergman, Amir M. Khoshiwal, Rebecca J. Critchley-Thorne, Katelyn Stebbins, Kees A. Seldenrijk, Emily A. Bossart, Roos E. Pouw, Kadere Konte
Publikováno v:
The American journal of gastroenterology, 116(4), 675-682. Springer Nature
American journal of gastroenterology, 116(4), 675-682. Springer Nature
Frei, N F, Khoshiwal, A M, Konte, K, Bossart, E A, Stebbins, K, Zhang, Y, Pouw, R E, ten Kate, F J W, Seldenrijk, K A, Meijer, S L, Critchley-Thorne, R J & Bergman, J J G H M 2021, ' Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia ', The American journal of gastroenterology, vol. 116, no. 4, pp. 675-682 . https://doi.org/10.14309/ajg.0000000000001037
American journal of gastroenterology, 116(4), 675-682. Springer Nature
Frei, N F, Khoshiwal, A M, Konte, K, Bossart, E A, Stebbins, K, Zhang, Y, Pouw, R E, ten Kate, F J W, Seldenrijk, K A, Meijer, S L, Critchley-Thorne, R J & Bergman, J J G H M 2021, ' Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia ', The American journal of gastroenterology, vol. 116, no. 4, pp. 675-682 . https://doi.org/10.14309/ajg.0000000000001037
Introduction Low-grade dysplasia (LGD) is the best predictor of neoplastic progression in Barrett's esophagus (BE). Most LGD cases are downstaged to nondysplastic (ND) BE on expert pathologist review, which is prone to interobserver variation and not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaa205cce734d9f4ff1803b3cd38842c
https://research.vumc.nl/en/publications/f5d3b1c4-af2f-432b-962a-8ab7c55b16bd
https://research.vumc.nl/en/publications/f5d3b1c4-af2f-432b-962a-8ab7c55b16bd
Autor:
Emily A. Bossart, Roos E. Pouw, Katelyn Stebbins, Kadere Konte, Yi Zhang, Nicola Frei, Jacques J. Bergman, Rebecca J. Critchley-Thorne
Publikováno v:
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 11(10):e00244. Nature Publishing Group
Clinical and Translational Gastroenterology
Frei, N F, Konte, K, Bossart, E A, Stebbins, K, Zhang, Y, Pouw, R E, Critchley-Thorne, R J & Bergman, J J G H M 2020, ' Independent validation of a tissue systems pathology assay to predict future progression in nondysplastic barrett's esophagus : A spatial-temporal analysis ', CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, vol. 11, no. 10, e00244 . https://doi.org/10.14309/ctg.0000000000000244
Clinical and translational gastroenterology, 11(10):e00244. Nature Publishing Group
Clinical and Translational Gastroenterology
Frei, N F, Konte, K, Bossart, E A, Stebbins, K, Zhang, Y, Pouw, R E, Critchley-Thorne, R J & Bergman, J J G H M 2020, ' Independent validation of a tissue systems pathology assay to predict future progression in nondysplastic barrett's esophagus : A spatial-temporal analysis ', CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, vol. 11, no. 10, e00244 . https://doi.org/10.14309/ctg.0000000000000244
Clinical and translational gastroenterology, 11(10):e00244. Nature Publishing Group
INTRODUCTION: An automated risk prediction assay has previously been shown to objectively identify patients with nondysplastic Barrett's esophagus (NDBE) who are at increased risk of malignant progression. To evaluate the predictive performance of th
Autor:
Charlotte F.J. van Tuijn, Jarom Heijmans, Kadere Konte, Erfan Nur, Man Wai Tang, Bart J. Biemond
Publikováno v:
Blood
Background: Sickle cell disease (SCD) is frequently complicated by painful vaso-occlusive crises (VOCs) often resulting in healthcare utilization including hospital admission. A vaso-occlusive crisis (VOC) can be induced by multiple factors including
Autor:
Mark Löwenberg, G. R. van den Brink, Kadere Konte, Christianne J. Buskens, G R D’Haens, CJ Ponsioen, Saloomeh Sahami, Pieter J. Tanis, W. A. Bemelman
Publikováno v:
United European gastroenterology journal, 5(4), 554-562. SAGE Publications Inc.
The primary objective of this study was to assess proximal disease extension of ulcerative colitis (UC) over time, with disease behaviour pattern and risk factors for proximal disease extension and colectomy as secondary aims. All cumulative incident